查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463763

研究抗体和试剂的全球市场:市场规模和占有率分析、工业需求预测（截至2030年）

Research Antibodies and Reagents Market Size and Share Report by Product, Type, Vertical, Source, Form, Technology, Application, End User - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 330 Pages | 商品交期: 2-3个工作天内

价格
简介目录

主要亮点

全球研究抗体和试剂市场预计2023年将达到120亿美元，到2030年将达到187亿美元，复合年增长率为6.7%。

对临床诊断、带因者筛检和新药不断增长的需求，以及遗传疾病数量的快速增加，正在推动产业成长。

重要见解

到2023年，试剂类别将占据最大占有率，约为60%，预计这一趋势将在未来10年持续下去。

预计到2023年，一抗将以约70%的占有率引领业界，并持续领先业界。

到2023年，肿瘤领域将占据最大市场占有率，约为35%，随着主要地区癌症发生率的上升，预计未来10年仍将保持最大市场占有率。

到 2023 年，北美将以约 55% 的占有率引领产业，并且由于生物技术和製药领域的高研发活动，预计未来几年将呈现强劲成长。

亚太地区预计将以本十年最快的速度发展。这是由于该地区国内外医疗和生物技术公司的资金增加所致。

本报告分析了全球研究用抗体和试剂市场，并提供了市场的基本结构、最新情况、主要促进和抑制因素以及全球、依地区和主要国家市场规模的前景等资讯（从货币角度来看，（ 2017-2030），依产品、类型、行业、原材料、形状、技术、应用、最终用户、当前市场竞争状况、主要公司概况等划分的详细趋势。

目录

第一章 调查范围

第二章 研究方法

第三章执行摘要

第四章 市场指标

第五章 产业展望

  • 市场动态
    • 趋势
    • 促进因素
    • 抑制因素/课题
    • 促进/抑制因素影响分析
  • 新型冠状病毒感染（COVID-19）的影响
  • 波特五力分析

第六章 世界市场

  • 概述
  • 市场收入：依产品分类（2017-2030）
    • 试剂市场收入：依类型分类（2017-2030）
  • 市场收入：依类型分类（2017-2030）
  • 市场收入：依行业分类（2017-2030）
  • 市场收入：依原料分类（2017-2030）
  • 市场收入：依形状分类（2017-2030）
  • 市场收入：依技术分类（2017-2030）
  • 市场收入：依应用分类（2017-2030）
  • 市场收入：依最终用户分类（2017-2030）
  • 市场收入：依地区（2017-2030）

第七章 北美市场

  • 概述
  • 市场收入：依产品分类（2017-2030）
    • 试剂市场收入：依类型分类（2017-2030）
  • 市场收入：依类型分类（2017-2030）
  • 市场收入：依行业分类（2017-2030）
  • 市场收入：依原料分类（2017-2030）
  • 市场收入：依形状分类（2017-2030）
  • 市场收入：依技术分类（2017-2030）
  • 市场收入：依应用分类（2017-2030）
  • 市场收入：依最终用户分类（2017-2030）
  • 市场收入：依国家分类（2017-2030）

第八章欧洲市场

第九章亚太市场

第十章 拉丁美洲市场

第十一章 中东/非洲市场

第十二章 美国市场

  • 概述
  • 市场收入：依产品分类（2017-2030）
    • 试剂市场收入：依类型分类（2017-2030）
  • 市场收入：依类型分类（2017-2030）
  • 市场收入：依行业分类（2017-2030）
  • 市场收入：依原料分类（2017-2030）
  • 市场收入：依形状分类（2017-2030）
  • 市场收入：依技术分类（2017-2030）
  • 市场收入：依应用分类（2017-2030）
  • 市场收入：依最终用户分类（2017-2030）

第十三章 加拿大市场

第十四章 德国市场

第十五章 法国市场

第十六章 英国市场

第十七章 义大利市场

第十八章 西班牙市场

第十九章 日本市场

第20章 中国市场

第21章 印度市场

第22章澳洲市场

第23章 韩国市场

第24章 巴西市场

第25章 墨西哥市场

第26章 沙乌地阿拉伯市场

第27章南非市场

第28章 阿拉伯联合大公国（UAE）市场

第29章竞争格局

  • 市场参与者及其提供的产品/服务的列表
  • 主要企业竞争基准
  • 主要公司的产品基准
  • 近期策略发展状况

第三十章 公司简介

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Abcam plc
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Teva Pharmaceutical Industries Limited
  • Eli Lilly and Company
  • Agilent Technologies Inc.

第31章附录

简介目录
Product Code: 12851

Key Highlights

The research antibodies & reagents market generated USD 12.0 billion in 2023, and it will touch USD 18.7 billion, with a 6.7% CAGR, by 2030.

The rising need for clinical diagnostics, carrier screening, and new drugs, along with the surging incidence of genetic disorders is aiding the industry's growth.

The swift technological improvement in pharmaceutical platforms, the substantial application of antibodies & reagents in biotechnology & pharmaceutical analyses, and growing funding and initiatives from private and government bodies for large-scale biotechnology projects resulted in the industry expansion.

The rising research activities to produce new medicines, get them into trials and have them approved boost this industry.

Governments are funding in such activities because of the increasing incidence of chronic and infectious ailments, for discovering effective treatments.

Therefore, life sciences research activities have shattered some records in terms of scientific advancements, funding, and the variety and quantity of new medicines that are accessible to patients across the globe.

The market made some ground-breaking contributions during the pandemic of COVID-19 in the form of vaccines and therapeutics, assisted by the effective application of various research antibodies & reagents.

Key Insights

The reagents category accounted for the largest share of the industry in 2023, of approximately 60%, and it will continue this trend throughout this decade.

The growing application of biotechnology and biosciences in the pharmaceutical and healthcare sectors and the increasing biotechnical and pharmaceutical research for finding more effective, new drugs are driving the reagents category.

Primary antibodies led the industry in 2023, with approximately 70% share, and it will remain leading in the coming years.

The growth in the primary antibodies is because of the extensive variety of utilities offered by these antibodies in the R&D space; and the increasing availability of primary antibodies using goats, mice, rabbits, and various other species as hosts.

The oncology category was the largest contributor to the industry in 2023, with approximately 35% share, and it will remain the largest during this decade, because of the increasing incidence of cancer in key geographies.

The mice category led the industry because of the smaller size and high reproduction rate of the antibodies & reagents produced using mouse tissue.

The western blotting category is leading the market because of the extensive accessibility and acceptance of this method in healthcare R&D.

Monoclonal antibodies led the industry, due to the rising count of cancer research projects, which require antibodies with high specificity.

Proteomics was the largest contributor in 2023, with approximately 40% share, and it will further propel at a robust rate in the coming years.

The demand for greater effectiveness when mapping drug-protein and protein-protein interactions is boosting the proteomics category.

North America led the industry in 2023, with a share of approximately 55%, and it will advance at a robust rate in the coming years, owing to the substantial biotechnology and pharmaceutical R&D activities.

APAC will propel at the fastest rate during this decade, owing to the increasing funding from both foreign and domestic healthcare and biotechnology firms in this region.

The research antibodies & reagents industry is dynamic and competitive. Competition is powered by technological improvements, the specific demands of different research areas, and product innovation.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by product
    • 1.4.2. Market size breakdown, by type
    • 1.4.3. Market size breakdown, by vertical
    • 1.4.4. Market size breakdown, by source
    • 1.4.5. Market size breakdown, by form
    • 1.4.6. Market size breakdown, by technology
    • 1.4.7. Market size breakdown, by application
    • 1.4.8. Market size breakdown, by end user
    • 1.4.9. Market size breakdown, by region
    • 1.4.10. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Product (2017-2030)
    • 6.2.1. Reagents market revenue, by type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Revenue, by Vertical (2017-2030)
  • 6.5. Market Revenue, by Source (2017-2030)
  • 6.6. Market Revenue, by Form (2017-2030)
  • 6.7. Market Revenue, by Technology (2017-2030)
  • 6.8. Market Revenue, by Application (2017-2030)
  • 6.9. Market Revenue, by End User (2017-2030)
  • 6.10. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Product (2017-2030)
    • 7.2.1. Reagents market revenue, by type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Revenue, by Vertical (2017-2030)
  • 7.5. Market Revenue, by Source (2017-2030)
  • 7.6. Market Revenue, by Form (2017-2030)
  • 7.7. Market Revenue, by Technology (2017-2030)
  • 7.8. Market Revenue, by Application (2017-2030)
  • 7.9. Market Revenue, by End User (2017-2030)
  • 7.10. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Product (2017-2030)
    • 8.2.1. Reagents market revenue, by type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Revenue, by Vertical (2017-2030)
  • 8.5. Market Revenue, by Source (2017-2030)
  • 8.6. Market Revenue, by Form (2017-2030)
  • 8.7. Market Revenue, by Technology (2017-2030)
  • 8.8. Market Revenue, by Application (2017-2030)
  • 8.9. Market Revenue, by End User (2017-2030)
  • 8.10. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Product (2017-2030)
    • 9.2.1. Reagents market revenue, by type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Revenue, by Vertical (2017-2030)
  • 9.5. Market Revenue, by Source (2017-2030)
  • 9.6. Market Revenue, by Form (2017-2030)
  • 9.7. Market Revenue, by Technology (2017-2030)
  • 9.8. Market Revenue, by Application (2017-2030)
  • 9.9. Market Revenue, by End User (2017-2030)
  • 9.10. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Product (2017-2030)
    • 10.2.1. Reagents market revenue, by type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Revenue, by Vertical (2017-2030)
  • 10.5. Market Revenue, by Source (2017-2030)
  • 10.6. Market Revenue, by Form (2017-2030)
  • 10.7. Market Revenue, by Technology (2017-2030)
  • 10.8. Market Revenue, by Application (2017-2030)
  • 10.9. Market Revenue, by End User (2017-2030)
  • 10.10. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Product (2017-2030)
    • 11.2.1. Reagents market revenue, by type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Revenue, by Vertical (2017-2030)
  • 11.5. Market Revenue, by Source (2017-2030)
  • 11.6. Market Revenue, by Form (2017-2030)
  • 11.7. Market Revenue, by Technology (2017-2030)
  • 11.8. Market Revenue, by Application (2017-2030)
  • 11.9. Market Revenue, by End User (2017-2030)
  • 11.10. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Product (2017-2030)
    • 12.2.1. Reagents market revenue, by type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Revenue, by Vertical (2017-2030)
  • 12.5. Market Revenue, by Source (2017-2030)
  • 12.6. Market Revenue, by Form (2017-2030)
  • 12.7. Market Revenue, by Technology (2017-2030)
  • 12.8. Market Revenue, by Application (2017-2030)
  • 12.9. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Product (2017-2030)
    • 13.2.1. Reagents market revenue, by type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Revenue, by Vertical (2017-2030)
  • 13.5. Market Revenue, by Source (2017-2030)
  • 13.6. Market Revenue, by Form (2017-2030)
  • 13.7. Market Revenue, by Technology (2017-2030)
  • 13.8. Market Revenue, by Application (2017-2030)
  • 13.9. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Product (2017-2030)
    • 14.2.1. Reagents market revenue, by type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Revenue, by Vertical (2017-2030)
  • 14.5. Market Revenue, by Source (2017-2030)
  • 14.6. Market Revenue, by Form (2017-2030)
  • 14.7. Market Revenue, by Technology (2017-2030)
  • 14.8. Market Revenue, by Application (2017-2030)
  • 14.9. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Product (2017-2030)
    • 15.2.1. Reagents market revenue, by type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Revenue, by Vertical (2017-2030)
  • 15.5. Market Revenue, by Source (2017-2030)
  • 15.6. Market Revenue, by Form (2017-2030)
  • 15.7. Market Revenue, by Technology (2017-2030)
  • 15.8. Market Revenue, by Application (2017-2030)
  • 15.9. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Product (2017-2030)
    • 16.2.1. Reagents market revenue, by type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Revenue, by Vertical (2017-2030)
  • 16.5. Market Revenue, by Source (2017-2030)
  • 16.6. Market Revenue, by Form (2017-2030)
  • 16.7. Market Revenue, by Technology (2017-2030)
  • 16.8. Market Revenue, by Application (2017-2030)
  • 16.9. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Product (2017-2030)
    • 17.2.1. Reagents market revenue, by type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Revenue, by Vertical (2017-2030)
  • 17.5. Market Revenue, by Source (2017-2030)
  • 17.6. Market Revenue, by Form (2017-2030)
  • 17.7. Market Revenue, by Technology (2017-2030)
  • 17.8. Market Revenue, by Application (2017-2030)
  • 17.9. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Product (2017-2030)
    • 18.2.1. Reagents market revenue, by type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Revenue, by Vertical (2017-2030)
  • 18.5. Market Revenue, by Source (2017-2030)
  • 18.6. Market Revenue, by Form (2017-2030)
  • 18.7. Market Revenue, by Technology (2017-2030)
  • 18.8. Market Revenue, by Application (2017-2030)
  • 18.9. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Product (2017-2030)
    • 19.2.1. Reagents market revenue, by type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Revenue, by Vertical (2017-2030)
  • 19.5. Market Revenue, by Source (2017-2030)
  • 19.6. Market Revenue, by Form (2017-2030)
  • 19.7. Market Revenue, by Technology (2017-2030)
  • 19.8. Market Revenue, by Application (2017-2030)
  • 19.9. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Product (2017-2030)
    • 20.2.1. Reagents market revenue, by type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Revenue, by Vertical (2017-2030)
  • 20.5. Market Revenue, by Source (2017-2030)
  • 20.6. Market Revenue, by Form (2017-2030)
  • 20.7. Market Revenue, by Technology (2017-2030)
  • 20.8. Market Revenue, by Application (2017-2030)
  • 20.9. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Product (2017-2030)
    • 21.2.1. Reagents market revenue, by type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Revenue, by Vertical (2017-2030)
  • 21.5. Market Revenue, by Source (2017-2030)
  • 21.6. Market Revenue, by Form (2017-2030)
  • 21.7. Market Revenue, by Technology (2017-2030)
  • 21.8. Market Revenue, by Application (2017-2030)
  • 21.9. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Product (2017-2030)
    • 22.2.1. Reagents market revenue, by type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Revenue, by Vertical (2017-2030)
  • 22.5. Market Revenue, by Source (2017-2030)
  • 22.6. Market Revenue, by Form (2017-2030)
  • 22.7. Market Revenue, by Technology (2017-2030)
  • 22.8. Market Revenue, by Application (2017-2030)
  • 22.9. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Product (2017-2030)
    • 23.2.1. Reagents market revenue, by type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Revenue, by Vertical (2017-2030)
  • 23.5. Market Revenue, by Source (2017-2030)
  • 23.6. Market Revenue, by Form (2017-2030)
  • 23.7. Market Revenue, by Technology (2017-2030)
  • 23.8. Market Revenue, by Application (2017-2030)
  • 23.9. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Product (2017-2030)
    • 24.2.1. Reagents market revenue, by type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Revenue, by Vertical (2017-2030)
  • 24.5. Market Revenue, by Source (2017-2030)
  • 24.6. Market Revenue, by Form (2017-2030)
  • 24.7. Market Revenue, by Technology (2017-2030)
  • 24.8. Market Revenue, by Application (2017-2030)
  • 24.9. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Product (2017-2030)
    • 25.2.1. Reagents market revenue, by type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Revenue, by Vertical (2017-2030)
  • 25.5. Market Revenue, by Source (2017-2030)
  • 25.6. Market Revenue, by Form (2017-2030)
  • 25.7. Market Revenue, by Technology (2017-2030)
  • 25.8. Market Revenue, by Application (2017-2030)
  • 25.9. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Product (2017-2030)
    • 26.2.1. Reagents market revenue, by type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Revenue, by Vertical (2017-2030)
  • 26.5. Market Revenue, by Source (2017-2030)
  • 26.6. Market Revenue, by Form (2017-2030)
  • 26.7. Market Revenue, by Technology (2017-2030)
  • 26.8. Market Revenue, by Application (2017-2030)
  • 26.9. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Product (2017-2030)
    • 27.2.1. Reagents market revenue, by type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Revenue, by Vertical (2017-2030)
  • 27.5. Market Revenue, by Source (2017-2030)
  • 27.6. Market Revenue, by Form (2017-2030)
  • 27.7. Market Revenue, by Technology (2017-2030)
  • 27.8. Market Revenue, by Application (2017-2030)
  • 27.9. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Product (2017-2030)
    • 28.2.1. Reagents market revenue, by type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Revenue, by Vertical (2017-2030)
  • 28.5. Market Revenue, by Source (2017-2030)
  • 28.6. Market Revenue, by Form (2017-2030)
  • 28.7. Market Revenue, by Technology (2017-2030)
  • 28.8. Market Revenue, by Application (2017-2030)
  • 28.9. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Thermo Fisher Scientific Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Merck KGaA
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Abcam plc
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Becton, Dickinson and Company
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. F. Hoffmann-La Roche Ltd.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. PerkinElmer Inc.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Bio-Rad Laboratories Inc.
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Teva Pharmaceutical Industries Limited
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Eli Lilly and Company
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Agilent Technologies Inc.
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports